Free Trial

Shattuck Labs (STTK) Competitors

Shattuck Labs logo
$1.11 -0.03 (-2.63%)
(As of 11/20/2024 ET)

STTK vs. SOPH, ZNTL, GNFT, SLN, INBX, ZURA, EDIT, SLDB, XBIT, and CRBP

Should you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include SOPHiA GENETICS (SOPH), Zentalis Pharmaceuticals (ZNTL), Genfit (GNFT), Silence Therapeutics (SLN), Inhibrx (INBX), Zura Bio (ZURA), Editas Medicine (EDIT), Solid Biosciences (SLDB), XBiotech (XBIT), and Corbus Pharmaceuticals (CRBP). These companies are all part of the "pharmaceutical products" industry.

Shattuck Labs vs.

SOPHiA GENETICS (NASDAQ:SOPH) and Shattuck Labs (NASDAQ:STTK) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, community ranking, earnings and institutional ownership.

SOPHiA GENETICS has higher revenue and earnings than Shattuck Labs. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SOPHiA GENETICS$62.37M3.32-$78.98M-$1.09-2.91
Shattuck Labs$1.66M31.92-$87.30M-$1.53-0.73

SOPHiA GENETICS presently has a consensus price target of $6.50, suggesting a potential upside of 105.05%. Shattuck Labs has a consensus price target of $8.67, suggesting a potential upside of 680.78%. Given Shattuck Labs' higher probable upside, analysts clearly believe Shattuck Labs is more favorable than SOPHiA GENETICS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SOPHiA GENETICS
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Shattuck Labs
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.40

In the previous week, Shattuck Labs had 10 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 12 mentions for Shattuck Labs and 2 mentions for SOPHiA GENETICS. SOPHiA GENETICS's average media sentiment score of 0.00 beat Shattuck Labs' score of -0.03 indicating that SOPHiA GENETICS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SOPHiA GENETICS
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Shattuck Labs
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SOPHiA GENETICS has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, Shattuck Labs has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500.

Shattuck Labs received 19 more outperform votes than SOPHiA GENETICS when rated by MarketBeat users. However, 72.00% of users gave SOPHiA GENETICS an outperform vote while only 71.15% of users gave Shattuck Labs an outperform vote.

CompanyUnderperformOutperform
SOPHiA GENETICSOutperform Votes
18
72.00%
Underperform Votes
7
28.00%
Shattuck LabsOutperform Votes
37
71.15%
Underperform Votes
15
28.85%

31.6% of SOPHiA GENETICS shares are held by institutional investors. Comparatively, 58.7% of Shattuck Labs shares are held by institutional investors. 4.9% of SOPHiA GENETICS shares are held by insiders. Comparatively, 10.5% of Shattuck Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SOPHiA GENETICS has a net margin of -110.71% compared to Shattuck Labs' net margin of -1,156.46%. SOPHiA GENETICS's return on equity of -55.06% beat Shattuck Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
SOPHiA GENETICS-110.71% -55.06% -38.33%
Shattuck Labs -1,156.46%-61.92%-54.49%

Summary

SOPHiA GENETICS beats Shattuck Labs on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STTK vs. The Competition

MetricShattuck LabsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$52.99M$6.45B$5.06B$8.82B
Dividend YieldN/A8.11%5.18%4.07%
P/E Ratio-0.7310.78126.3117.81
Price / Sales8.23243.711,178.7474.57
Price / CashN/A22.1633.8632.53
Price / Book0.335.474.684.68
Net Income-$87.30M$153.61M$119.54M$226.08M
7 Day Performance-18.98%-2.00%-1.83%-1.04%
1 Month Performance-11.20%-7.46%-3.60%1.04%
1 Year Performance-51.53%31.82%31.91%26.28%

Shattuck Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STTK
Shattuck Labs
2.8247 of 5 stars
$1.11
-2.6%
$8.67
+680.8%
-50.7%$54.42M$1.66M-0.73100Analyst Revision
SOPH
SOPHiA GENETICS
1.4237 of 5 stars
$3.17
-3.1%
$6.50
+105.0%
-14.6%$213.78M$62.37M0.00520
ZNTL
Zentalis Pharmaceuticals
2.5896 of 5 stars
$3.13
+4.7%
$10.00
+219.5%
-71.1%$213.08MN/A0.00160Analyst Revision
GNFT
Genfit
1.4608 of 5 stars
$4.31
+1.2%
$13.00
+201.6%
+27.1%$212.95M$41.31M0.00120
SLN
Silence Therapeutics
3.646 of 5 stars
$6.93
-0.6%
$57.20
+725.4%
-27.1%$208.60M$31.55M0.00100Analyst Forecast
News Coverage
High Trading Volume
INBX
Inhibrx
1.2884 of 5 stars
$14.04
-1.7%
N/A-36.9%$206.86M$1.63M0.00166
ZURA
Zura Bio
3.9055 of 5 stars
$2.90
-7.9%
$15.80
+444.8%
-35.1%$205.68MN/A0.003Analyst Forecast
EDIT
Editas Medicine
4.7809 of 5 stars
$2.41
-2.8%
$9.08
+276.9%
-77.8%$204.72M$78.12M-0.94230Short Interest ↓
SLDB
Solid Biosciences
3.3235 of 5 stars
$4.96
-2.9%
$15.14
+205.3%
+108.4%$204.17M$8.09M-1.63100Analyst Revision
XBIT
XBiotech
0.8946 of 5 stars
$6.49
-2.7%
N/A+77.8%$203.32M$4.01M-6.01100Positive News
CRBP
Corbus Pharmaceuticals
4.8781 of 5 stars
$16.08
-2.9%
$65.86
+309.6%
+249.6%$201.69M$880,000.00-3.4340Positive News

Related Companies and Tools


This page (NASDAQ:STTK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners